Vol. 1 No. 1 (2025), Articles
Vol. 1 No. 1 (2025)

MODERN CLASSIFICATIONS AND DIAGNOSTIC METHODS OF CHRONIC HEART FAILURE

Articles
Published 2026-01-28
Baxtiyor Abdurasulov
Lecturer, Department of Clinical Sciences, Namangan State University
Umid Musashayxov
PhD, Head of the Department of Internal Medicine, Andijan State Medical Institute
Mirzoxid Turabbayev
Physician, Namangan Regional Multidisciplinary Medical Center
PDF

Keywords

chronic heart failure, natriuretic peptide, arterial hypertension, left ventricular ejection fraction, ECHO

How to Cite

Abdurasulov , B., Musashayxov , U., & Turabbayev , M. (2026). MODERN CLASSIFICATIONS AND DIAGNOSTIC METHODS OF CHRONIC HEART FAILURE. INTERNATIONAL MULTIDISCIPLINARY SCIENCE CONFERENCE, 1(1), 39-43. https://doi.org/10.5281/zenodo.18405669
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Chronic heart failure is a syndrome encountered in a number of diseases, characterized by fluid accumulation in soft tissues resulting from the heart's inability to adequately supply organs and tissues with blood during physical exertion or at rest. Echocardiography (ECHO) currently plays an important role in the diagnosis of chronic heart failure. In recent years, the detection of specific biomarkers for chronic heart failure has also been established. Natriuretic peptide is among these.

PDF

References

1. Muromtseva G.A., Kontsevaya A.V., Konstantinov V.V. va boshqalar. 2012-2013 yillarda Rossiya aholisida yuqumli bo'lmagan kasalliklar uchun xavf omillarining tarqalishi. ESSE-RF tadqiqotining natijalari. Yurak-qon tomir terapiyasi va oldini olish 2014;13(6):4-11.

2. Kearney PM, Whelton M, Reynolds K va boshqalar. Gipertenziyaning global yuki: butun dunyo bo'ylab ma'lumotlar tahlili. Lancet. 2005;365:217-23.

3. Franklin SS, Lopez VA, Wong ND va boshqalar. Qon bosimining bir yoki birlashtirilgan komponentlari va yurak-qon tomir kasalliklari xavfi: Framingham yurak tadqiqoti. Qon aylanishi. 2009;119:243-50.

4. Williams B, Mancia G, Spiering W va boshqalar. 2018-yilgi ESC/ESH Arterial gipertenziyani davolash bo'yicha ko'rsatmalar: Yevropa Kardiologiya Jamiyati va Yevropa Gipertenziya Jamiyatining arterial gipertenziyani davolash bo'yicha ishchi guruhi:, Yevropa Kardiologiya Jamiyati va Yevropa Gipertenziya Jamiyatining arterial gipertenziyani davolash bo'yicha ishchi guruhi. J Hypertens. 2018;36(10):1953-2041.

5. Groenewegen A, Rutten FH, Mosterd A va boshqalar. Yurak yetishmovchiligi epidemiologiyasi. Yurak yetishmovchiligi bo'yicha Yevropa jurnali. 2020;22(8):1342-56.https://doi.org/10.1002/ejhf.1858.

6. O.O.Shaxmatova. "Biomarkerlar mukammal emas": yurak yetishmovchiligi bilan og‘rigan bemorlarda chiqarish fraktsiyasi saqlanib qolgan va normal natriuretik peptid darajasiga ega bemorlarda o‘lim va kasalxonaga yotqizish xavfi yuqori.

Akademik E.I. Chazov nomidagi Milliy kardiologiya tadqiqot markazi

7. E.A. Matova, t.f.n., Arterial gipertenziya va yurak yetishmovchiligi. Ukraina Tibbiyot fanlari akademiyasining “N.D. Strajesko nomidagi kardiologiya institute” milliy ilmiy markazi, Kiyev.

8. Chaulin A.M., Duplyakov D.V. Yurak yetishmovchiligi bilan bog‘liq bo‘lmagan natriuretik peptidlarning ko‘tarilishi. Rossiya kardiologiya jurnali. 2020;25(4S):4140. https://doi.org/10.15829/1560-4071-2020-4140

9. https://scardio.ru/content/Guidelines/2020/Clinic_rekom_HSN.pdf).